# Daniel F. Hayes

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-f-hayes/

## Facts

| Field | Value |
| --- | --- |
| Citations | 100,616 |
| Field | Breast Cancer Treatment Studies |
| h-index | 128 |
| i10-index | 403 |
| Last Known Institution | University of Michigan |
| OpenAlex ID | https://openalex.org/A5069748055 |
| ORCID iD | https://orcid.org/0000-0003-3620-7575 |
| Works | 826 |

## Researcher papers

Showing 12 of 16.

- [Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013](https://scholariq.org/papers/personalizing-the-treatment-of-women-with-early-breast-cancer-highlights-of-the/)
- [American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer](https://scholariq.org/papers/american-society-of-clinical-oncology-2007-update-of-recommendations-for-the-use/)
- [Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group](https://scholariq.org/papers/assessment-of-ki67-in-breast-cancer-recommendations-from-the-international-ki67/)
- [Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update](https://scholariq.org/papers/estrogen-and-progesterone-receptor-testing-in-breast-cancer-asco-cap-guideline/)
- [Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial](https://scholariq.org/papers/prognostic-and-predictive-value-of-the-21-gene-recurrence-score-assay-in/)
- [De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017](https://scholariq.org/papers/de-escalating-and-escalating-treatments-for-early-stage-breast-cancer-the-st/)
- [Revision of the American Joint Committee on Cancer Staging System for Breast Cancer](https://scholariq.org/papers/revision-of-the-american-joint-committee-on-cancer-staging-system-for-breast/)
- [Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials](https://scholariq.org/papers/long-term-outcomes-for-neoadjuvant-versus-adjuvant-chemotherapy-in-early-breast/)
- [Prognostic Factors in Breast Cancer](https://scholariq.org/papers/prognostic-factors-in-breast-cancer/)
- [Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review](https://scholariq.org/papers/circulating-tumor-dna-analysis-in-patients-with-cancer-american-society-of/)
- [Integrative clinical genomics of metastatic cancer](https://scholariq.org/papers/integrative-clinical-genomics-of-metastatic-cancer/)
- [Cancer biomarkers](https://scholariq.org/papers/cancer-biomarkers/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [University of Michigan](https://scholariq.org/institutions/university-of-michigan/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.